Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001005477-07-002289
Filing Date
2007-04-02
Accepted
2007-04-02 16:08:21
Documents
1
Period of Report
2007-03-29

Document Format Files

Seq Description Document Type Size
1 FORM 4 edgar123.html 4  
1 FORM 4 edgar123.xml 4 3935
  Complete submission text file 0001005477-07-002289.txt   5780
Mailing Address 299 PARK AVENUE 22ND FL NEW YORK NY 10171
Business Address 2128912120
FEINBERG STEPHEN (Reporting) CIK: 0000947822 (see all company filings)

State of Incorp.: NY | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-33284 | Film No.: 07739077

Mailing Address 160 SECOND STREET CAMBRIDGE MA 02142
Business Address 160 SECOND STREET CAMBRIDGE MA 02142 617-492-5554
Molecular Insight Pharmaceuticals, Inc. (Issuer) CIK: 0001340752 (see all company filings)

EIN.: 043412465 | State of Incorp.: MA | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations